Search Within

Mark Andrew Dickson

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (14)
Groups
  1. Body Imaging Service (28)
  2. Department of Medicine (28)
  3. Molecular Imaging and Therapy Service (28)
  4. Radiology, Department of (28)
  5. Sarcoma Service (28)
  6. Solid Tumor Oncology Division (28)

More Groups

People
  1. William Tap (28)
  2. Mary Keohan (26)
  3. Mrinal Gounder (26)
  4. Sandra D'Angelo (26)
  5. Li-Xuan Qin (23)
  6. Ping Chi (23)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (4)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Clinical Cancer Research (4)
  3. JAMA Oncology (2)
  4. The Oncologist (2)
  5. Annals of Oncology (1)
  6. European Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (14)
  2. American Association for Cancer Research (4)
  3. Oxford University Press (3)
  4. American Medical Association (2)
  5. Elsevier Inc. (1)
  6. Hindawi Publishing Corporation (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase IB/IL study of gemcitabine and docetaxel in combination with pazopanib for the neoadjuvant treatment of soft tissue sarcomas
    Journal Article

    Munhoz, R. R.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Carvajal, R. D.; Singer, S.; Crago, A. M.; Landa, J.; Healey, J. H.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Outcomes of systemic therapy for patients with metastatic angiosarcoma
    Journal Article

    D'Angelo, S. P.; Munhoz, R. R.; Kuk, D.; Landa, J.; Hartley, E. W.; Bonafede, M.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; Crago, A. M.; more...
    Oncology (2015)

    Fulltext@MSK | Save
  • Metastatic non-uterine leiomyosarcoma: Prognostic factors, overall survival and chemotherapy outcomes
    Meeting Abstract

    D'Angelo, S. P.; Shoushtari, A. N.; Landa, J.; Kuk, D.; Sanchez, A. J.; Lala, B.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Tap, W. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase Ib/II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Shoushtari, A. N.; Condy, M. M.; Konen, T.; Fruauff, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Final results of sequential phase 2 studies of palbociclib (PD0332991) in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M.; Tap, W. D.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; Singer, S.; Schwartz, G. K.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma
    Journal Article

    Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; Condy, M. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Keohan, M. L.; Tap, W. D.; Antonescu, C.; Landa, J.; Qin, L. X.; Dohrenwend, E. G.; Rathbone, D.; Ustoyev, Y.; Condy, M. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save